乌干达HIV抗逆转录病毒治疗患者跟骨定量超声与尿视黄醇结合蛋白初步研究
本研究在乌干达坎帕拉对101名接受≥10年抗逆转录病毒治疗的HIV成人进行横断面研究,发现跟骨定量超声参数与双能X线吸收法骨密度显著相关(P<.01),47%患者尿视黄醇结合蛋白/肌酐比值异常,且该比值与骨密度T值呈显著负相关。结论提示跟骨定量超声与双能X线吸收法中度相关,亚临床肾小管损伤高发,强调资源有限地区需扩大替诺福韦二吡呋酯减量方案的可及性。
要点
- 跟骨定量超声与双能X线吸收法骨密度显著相关,或可用于资源有限地区筛查。
- 47%长期抗逆转录病毒治疗患者存在尿视黄醇结合蛋白/肌酐比值异常。
- 尿视黄醇结合蛋白/肌酐比值与腰椎、股骨颈和全髋T值呈显著负相关。
核心结论
- 跟骨定量超声结果与双能X线吸收法输出呈中度相关。
- 亚临床肾小管损伤高发,提示资源有限地区需扩大替诺福韦二吡呋酯减量方案可及性。
研究设计与样本
- 在乌干达坎帕拉传染病研究所开展的横断面研究。
- 纳入101名接受持续抗逆转录病毒治疗≥10年且过去12个月内接受过双能X线吸收法检查的HIV感染成人。
- 所有患者接受跟骨定量超声评估并采集尿液样本。
主要发现
- 双能X线吸收法骨密度测量与跟骨声速、宽带超声衰减和定量超声指数显著相关(P < .01)。
- 47名个体(47%)尿视黄醇结合蛋白/肌酐比值异常。
- 尿视黄醇结合蛋白/肌酐比值与双能X线吸收法T值呈显著负相关:腰椎(P = .03)、股骨颈(P < .001)、全髋(P = .002)。
临床怎么用
- 在资源有限地区可考虑跟骨定量超声作为骨密度减低的筛查工具。
- 对长期抗逆转录病毒治疗患者应关注肾小管功能,必要时检测尿视黄醇结合蛋白/肌酐比值。
- 亚临床肾小管损伤高发提示需评估替诺福韦二吡呋酯减量方案的适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data on bone health and renal impairment in people with human immunodeficiency virus (HIV) in resource-limited settings are limited. The primary aim of this study was to investigate the potential role of calcaneal quantitative ultrasonography (QUS) in predicting bone mineral density (BMD) reduction in a population of Ugandan HIV-infected individuals receiving long-term antiretroviral therapy; the secondary end point was to assess the prevalence of proximal tubular dysfunction and the correlation between elevated urinary retinol-binding protein-urinary creatinine ratio (uRBP/uCr) and reduced BMD. METHODS: We conducted a cross-sectional study at the Infectious Diseases Institute, Kampala, Uganda. We included 101 HIV-infected adults who had been receiving continuous antiretroviral therapy for ≥10 years and had undergone dual-energy x-ray absorptiometry (DXA) during the previous 12 months. All patients underwent calcaneal QUS evaluation and urine sample collection. RESULTS: DXA BMD measurements were significantly associated (P < .01) with calcaneal speed of sound, broadband ultrasound attenuation, and QUS index. Forty-seven individuals (47%) had abnormal uRBP/uCr values. A significant inverse correlation was observed between uRBP/uCr and DXA T scores (lumbar [P = .03], femoral neck [P < .001], and total hip [P = .002]). CONCLUSIONS: Calcaneal QUS results showed a moderate correlation with DXA outputs. The identified high prevalence of subclinical tubular impairment also highlights the importance of expanding access to tenofovir disoproxil fumarate-sparing regimens in resource-limited settings.
引用
- Costa C, Scabini S, Kaimal A, et al. Calcaneal Quantitative Ultrasonography and Urinary Retinol-Binding Protein in Antiretroviral-Treated Patients With Human Immunodeficiency Virus in Uganda: A Pilot Study. J Infect Dis. 2020. PMID: 32112093. doi:10.1093/infdis/jiaa088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。